4-78466310-A-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2PP3
The NM_025074.7(FRAS1):c.7132A>T(p.Lys2378*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025074.7 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Fraser syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Fraser syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- renal agenesis, unilateralInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_025074.7. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FRAS1 | NM_025074.7 | MANE Select | c.7132A>T | p.Lys2378* | stop_gained | Exon 50 of 74 | NP_079350.5 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| FRAS1 | ENST00000512123.4 | TSL:5 MANE Select | c.7132A>T | p.Lys2378* | stop_gained | Exon 50 of 74 | ENSP00000422834.2 | ||
| FRAS1 | ENST00000682513.1 | c.7132A>T | p.Lys2378* | stop_gained | Exon 50 of 64 | ENSP00000508201.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 54
GnomAD4 genome Cov.: 31
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at